Aspirin use is associated with attenuated risk of severe acute kidney injury in septic patients: a dual-center retrospective analysis from MIMIC-IV and eICU cohorts

作者
Yaru Luo,Hongyi Li,Jian Li,Danyang Li,Zhen Qiu,Shaoqing Lei,Qiaochu Fu,Zhongyuan Xia
出处
期刊:Renal Failure [Taylor & Francis]
卷期号:47 (1): 2568650-2568650
标识
DOI:10.1080/0886022x.2025.2568650
摘要

Sepsis is a systemic inflammatory response syndrome caused by infection, and sepsis-associated acute kidney injury (AKI) markedly increases mortality. Although aspirin's anti-inflammatory properties show therapeutic promise in sepsis, its specific renal protective effects in septic patients remain underexplored. This study investigated the association between aspirin exposure and severe acute kidney injury in septic patients using two databases: MIMIC-IV (73,181 ICU stays, 2008-2022), and eICU (200,859 ICU stays, 2014-2015). Among 45,562 septic patients, cohorts were stratified by aspirin exposure, and outcome variables were compared using multiple statistical adjustment methods including multivariable regression and propensity score analysis. The primary outcome was severe AKI incidence, with secondary outcomes including overall AKI, continuous renal replacement therapy (CRRT), and mortality. Our study suggests that aspirin exposure was associated with significantly lower severe AKI incidence in both databases (adjusted OR 0.35 in MIMIC-IV; 0.84 in eICU), representing risk reductions ranging from 16% to 65%. Secondary outcomes showed that aspirin exposure was associated with reduced kidney injury incidence, mortality rates and continuous renal replacement therapy requirements. These protective associations were consistent with sensitivity analyses and subgroup analyses. Furthermore, these protective effects were observed across different aspirin doses and formulations. However, aspirin may also increase the risk of thrombocytopenia and gastrointestinal bleeding. Our findings suggest that aspirin may be associated with reduced risk of sepsis-related kidney injury and mortality. Nevertheless, prospective randomized controlled trials are needed to confirm these associations, and individualized risk-benefit assessments remain essential before clinical application.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zz完成签到,获得积分10
刚刚
molihuakai应助吱吱采纳,获得30
刚刚
阿氏之光完成签到,获得积分10
1秒前
dinnas完成签到,获得积分10
1秒前
1秒前
qq关注了科研通微信公众号
1秒前
1秒前
1秒前
2秒前
2秒前
T510发布了新的文献求助30
2秒前
满意乐珍完成签到,获得积分10
2秒前
平常怀亦发布了新的文献求助10
2秒前
粗犷的汲完成签到,获得积分10
3秒前
molihuakai应助小亮采纳,获得30
3秒前
直率雪曼发布了新的文献求助10
3秒前
慕青应助超级洋葱采纳,获得10
3秒前
123456完成签到,获得积分10
3秒前
4秒前
4秒前
5秒前
5秒前
霍紫菡发布了新的文献求助10
5秒前
满意乐珍发布了新的文献求助10
5秒前
李健的小迷弟应助丹丹采纳,获得10
5秒前
5秒前
6秒前
小蘑菇应助沈卿卿采纳,获得10
6秒前
6秒前
6秒前
叶子发布了新的文献求助10
6秒前
6秒前
iNk应助五五采纳,获得20
7秒前
英俊的铭应助开心的梦桃采纳,获得10
7秒前
顺利毕业发布了新的文献求助10
7秒前
7秒前
坦率雁卉发布了新的文献求助10
7秒前
8秒前
Lucas应助马马采纳,获得10
8秒前
飞越发布了新的文献求助30
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
适配Micro-LED色转换的高兼容性量子点负性光刻胶制备与工艺研究 500
Direct and Iterative Linear System Solvers 500
Vander's Renal Physiology第10版 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7308172
求助须知:如何正确求助?哪些是违规求助? 8925714
关于积分的说明 18914784
捐赠科研通 6970796
什么是DOI,文献DOI怎么找? 3212712
关于科研通互助平台的介绍 2381331
邀请新用户注册赠送积分活动 2190477